María Fernanda García

Discovery of Potent EGFR Inhibitors through the Incorporation of a 3D‐Aromatic‐Boron‐Rich‐Cluster into the 4‐Anilinoquinazoline Scaffold: Potential Drugs for Glioma Treatment

Marcos Couto, María Fernanda García, Catalina Alamón et al. · Chemistry - A European Journal · 2017 · 81 citations

Pharmacy, Medicinal Chemistry, Pharmacology +17

Comparative study of the expression of metalloproteases and their inhibitors in different localizations within primary tumours and in metastatic lymph nodes of breast cancer

María Fernanda García, Salomé González‐Reyes, Luis O. González et al. · International Journal of Experimental Pathology · 2010 · 33 citations · Full text

Medicine, Oncology, Pathology +16

Sunitinib-Containing Carborane Pharmacophore with the Ability to Inhibit Tyrosine Kinases Receptors FLT3, KIT and PDGFR-β, Exhibits Powerful In Vivo Anti-Glioblastoma Activity

Catalina Alamón, Belén Dávila, María Fernanda García et al. · Cancers · 2020 · 30 citations · Full text

Medicine, Oncology, Pharmacology +17

A Potential Boron Neutron Capture Therapy Agent Selectively Suppresses High-Grade Glioma: <i>In Vitro</i> and <i>in Vivo</i> Exploration

Catalina Alamón, Belén Dávila, María Fernanda García et al. · Molecular Pharmaceutics · 2023 · 26 citations · Full text

Medicine, Oncology, Pharmacology +17

Technetium-99m- or Cy7-Labeled Rituximab as an Imaging Agent for Non-Hodgkin Lymphoma

Ximena Camacho, Camila Maria Longo Machado, María Fernanda García et al. · Oncology · 2017 · 24 citations

Medicine, Nuclear Medicine, Oncology +17